Everence Capital Management Inc Gilead Sciences, Inc. Transaction History

Everence Capital Management Inc

$1.54 Billion
Q4 2024

A detailed history of Everence Capital Management Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Everence Capital Management Inc holds 34,790 shares of GILD stock, worth $3.62 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

34,790

Previous 34,260 1.55%

Holding current value

$3.62 Million

Previous $2.87 Million 11.91%

% of portfolio

0.21%

Previous 0.18%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 03, 2025	BUY	$83.95 - $97.9 $44,493 - $51,887	530 Added 1.55%	34,790 $3.21 Million
Q3 2024 Oct 21, 2024	SELL	$66.59 - $83.99 $358,920 - $452,706	-5,390 Reduced 13.59%	34,260 $2.87 Million
Q4 2023 Jan 30, 2024	SELL	$73.27 - $83.09 $75,468 - $85,582	-1,030 Reduced 2.53%	39,650 $3.21 Million
Q3 2023 Oct 16, 2023	BUY	$73.94 - $80.67 $346,039 - $377,535	4,680 Added 13.0%	40,680 $3.05 Million
Q2 2023 Jul 14, 2023	SELL	$76.01 - $86.7 $237,911 - $271,371	-3,130 Reduced 8.0%	36,000 $2.77 Million
Q1 2023 Apr 04, 2023	SELL	$77.31 - $88.08 $24,739 - $28,185	-320 Reduced 0.81%	39,130 $3.25 Million
Q4 2022 Jan 31, 2023	BUY	$62.32 - $89.47 $990,888 - $1.42 Million	15,900 Added 67.52%	39,450 $3.39 Million
Q1 2022 Apr 11, 2022	SELL	$57.92 - $72.58 $527,072 - $660,478	-9,100 Reduced 27.87%	23,550 $1.4 Million
Q4 2020 Feb 01, 2021	SELL	$56.65 - $64.55 $645,810 - $735,870	-11,400 Reduced 25.88%	32,650 $1.9 Million
Q3 2020 Feb 01, 2021	BUY	$62.1 - $78.08 $593,055 - $745,664	9,550 Added 27.68%	44,050 $2.78 Million
Q4 2019 Jan 28, 2020	BUY	$61.62 - $67.78 $463,998 - $510,383	7,530 Added 27.92%	34,500 $2.24 Million
Q2 2019 Aug 02, 2019	BUY	$61.87 - $69.38 $200,458 - $224,791	3,240 Added 13.65%	26,970 $1.82 Million
Q1 2019 May 06, 2019	SELL	$62.53 - $70.05 $424,641 - $475,709	-6,791 Reduced 22.25%	23,730 $1.54 Million
Q4 2017 Feb 02, 2018	BUY	$71.15 - $83.52 $60,406 - $70,908	849 Added 2.86%	30,521 $2.19 Million
Q3 2017 Oct 31, 2017	BUY	$72.11 - $85.47 $2.14 Million - $2.54 Million	29,672	29,672 $2.4 Million

Others Institutions Holding GILD

# of Institutions

2,072

Shares Held

1.02B

Call Options Held

9.63M

Put Options Held

10.2M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $130B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Everence Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Everence Capital Management Inc with notifications on news.

Account

Everence Capital Management Inc Gilead Sciences, Inc. Transaction History